|
PGM3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.600400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.251200E-01 |
| Normal-vs-Stage2 |
2.381600E-02 |
| Normal-vs-Stage3 |
2.847800E-02 |
| Normal-vs-Stage4 |
2.245500E-02 |
| Stage1-vs-Stage2 |
7.822300E-02 |
| Stage1-vs-Stage3 |
1.535640E-01 |
| Stage1-vs-Stage4 |
1.068380E-01 |
| Stage2-vs-Stage3 |
4.608000E-01 |
| Stage2-vs-Stage4 |
6.749400E-01 |
| Stage3-vs-Stage4 |
7.717800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.232400E-02 |
| Normal-vs-AfricanAmerican |
8.681400E-01 |
| Normal-vs-Asian |
1.711840E-01 |
| Caucasian-vs-AfricanAmerican |
2.733000E-01 |
| Caucasian-vs-Asian |
9.073600E-01 |
| AfricanAmerican-vs-Asian |
3.552400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.778900E-03 |
| Normal-vs-Female |
1.292430E-01 |
| Male-vs-Female |
7.406100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.705400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.542470E-02 |
| Normal-vs-Age(61-80Yrs) |
4.343000E-03 |
| Normal-vs-Age(81-100Yrs) |
6.569400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.011770E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.236800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.463200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.843200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.936800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.224800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.734000E-01 |
| Classical-VS-Follicular |
4.585800E-02 |
| Classical-VS-Other |
6.834000E-02 |
| Classical-VS-Normal |
2.714400E-01 |
| Tall-VS-Follicular |
3.168800E-01 |
| Tall-VS-Other |
1.325020E-01 |
| Tall-VS-Normal |
2.502000E-01 |
| Follicular-VS-Other |
4.506200E-01 |
| Follicular-VS-Normal |
1.400270E-02 |
| Other-VS-Normal |
2.011600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.243710E-02 |
| Normal-vs-N1 |
1.226610E-01 |
| N0-vs-N1 |
6.603400E-01 |
|
|
